Stay updated on Intranasal Ketamine in Autism Social Impairment Clinical Trial
Sign up to get notified when there's something new on the Intranasal Ketamine in Autism Social Impairment Clinical Trial page.

Latest updates to the Intranasal Ketamine in Autism Social Impairment Clinical Trial page
- Check2 days agoChange DetectedA banner was added announcing NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and linking to related updates and FAQs.SummaryDifference1%

- Check8 days agoChange DetectedThe footer's revision identifier changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1; the 403 Forbidden page remains otherwise unchanged.SummaryDifference0.2%

- Check36 days agoChange DetectedA 403 Forbidden error content is displayed in place of the study record, signaling blocked access to the page. The visible structure remains, but the main content shows an error instead of the study details.SummaryDifference18%

- Check57 days agoChange DetectedThe page now reflects revision v3.6.6, replacing v3.6.5, indicating a small update to the page’s content or layout without changing the study details.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page now shows Revision: v3.6.5 in the footer, replacing Revision: v3.6.4, indicating a small update to the page template.SummaryDifference0.1%

Stay in the know with updates to Intranasal Ketamine in Autism Social Impairment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intranasal Ketamine in Autism Social Impairment Clinical Trial page.